UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000011121
Receipt number R000012839
Scientific Title Search for RNA Markers of Ocular Diseases
Date of disclosure of the study information 2013/07/05
Last modified on 2022/01/28 22:07:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Search for RNA Markers of Ocular Diseases

Acronym

Ocular Disease RNA Markers

Scientific Title

Search for RNA Markers of Ocular Diseases

Scientific Title:Acronym

Ocular Disease RNA Markers

Region

Japan


Condition

Condition

Glaucoma, Cataract, age-related macular degeneration, myopia, Corneal disease, Retinal disease, vitreous disease, infection

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

The purpose of this study is finding biomarkers of ocular diseases. It is very important for realizing early detection and early diagnosis to find the ocular disease biomarkers, which will prevent vision loss, reduce realization of unnecessary medical treatment, and effective medical treatment. Especially the disease that occupies the higher rank cause of the present halfway vision loss has many diseases which a prevalence rate increases with aging, and discovery of the new biomarker used as the key of a sick advance is desired.

Basic objectives2

Others

Basic objectives -Others

The 2nd purpose of this research is to find out the mechanism of ocular pathological conditions by grasping the molecular group to which an expression level is specifically changed for a disease. The pathology of an eye disease still has many unsolved things, and their elucidation from the new side is desired. They can become a hint for solving pathology with specific new RNA information.

Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Transcriptome information on ingredients, contained in biological samples from patients with ocular diseases

Key secondary outcomes

Information on ingredients other than RNA, such as protein and sugar, contained in biological samples from patients with ocular diseases


Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patients who undergo an ocular operation and the patients who consults ophthalmology at Tohoku University Hospital, because of cataract, glaucoma, corneal deceases, retinal deceases, vitreous deceases, age-related macular degeneration, infection, and high myopia.

Key exclusion criteria

none.

Target sample size

1250


Research contact person

Name of lead principal investigator

1st name Toru
Middle name
Last name Nakazawa

Organization

Tohoku University Graduate School of Medicine

Division name

Ophthalmology

Zip code

9808574

Address

1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, JAPAN

TEL

0227177294

Email

ntoru@oph.med.tohoku.ac.jp


Public contact

Name of contact person

1st name Hiroshi
Middle name
Last name Kunikata

Organization

Tohoku University Graduate School of Medicine

Division name

Ophthalmology

Zip code

9808574

Address

1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, JAPAN

TEL

0227177294

Homepage URL

http://www.oph.med.tohoku.ac.jp

Email

kunikata@oph.med.tohoku.ac.jp


Sponsor or person

Institute

Tohoku University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Tohoku Universit

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee Tohoku University Graduate School of Medicine

Address

2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, JAPAN

Tel

022-717-8007

Email

med-kenkyo@grp.tohoku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東北大学病院、東北大学大学院医学系研究科


Other administrative information

Date of disclosure of the study information

2013 Year 07 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

64

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 10 Month 22 Day

Date of IRB

2012 Year 10 Month 22 Day

Anticipated trial start date

2012 Year 11 Month 27 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Molecules, including transcriptome, proteome, and so on, that obtained from patients suffered from ocular diseases , were analyzed for finding biomarkers of ocular diseases.


Management information

Registered date

2013 Year 07 Month 04 Day

Last modified on

2022 Year 01 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012839


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name